Cite
P-0195 CLINICAL VALIDATION OF A NOVEL MULTIPLEX KIT FOR ALL RAS MUTATIONS IN COLORECTAL CANCER: RESULTS OF RASKET (RAS KEY TESTING) PROSPECTIVE MULTICENTER STUDY.
MLA
Toshihiro, Kudo, et al. “P-0195 Clinical Validation of a Novel Multiplex Kit for All Ras Mutations in Colorectal Cancer: Results of Rasket (Ras Key Testing) Prospective Multicenter Study.” Annals of Oncology, vol. 25, no. suppl_2, June 2014, p. ii73. EBSCOhost, https://doi.org/10.1093/annonc/mdu165.190.
APA
Toshihiro, K., Taroh, S., Kei, M., Hiroya, T., Kensei, Y., Kiwamu, A., Tomohiro, N., Takeshi, K., Tadamichi, D., Shuichi, H., Wataru, O., & Takayuki, Y. (2014). P-0195 Clinical Validation of a Novel Multiplex Kit for All Ras Mutations in Colorectal Cancer: Results of Rasket (Ras Key Testing) Prospective Multicenter Study. Annals of Oncology, 25(suppl_2), ii73. https://doi.org/10.1093/annonc/mdu165.190
Chicago
Toshihiro, Kudo, Satoh Taroh, Muro Kei, Taniguchi Hiroya, Yamaguchi Kensei, Akagi Kiwamu, Nishina Tomohiro, et al. 2014. “P-0195 Clinical Validation of a Novel Multiplex Kit for All Ras Mutations in Colorectal Cancer: Results of Rasket (Ras Key Testing) Prospective Multicenter Study.” Annals of Oncology 25 (suppl_2): ii73. doi:10.1093/annonc/mdu165.190.